Cue Biopharma, Inc. — Director's Dealing 2020

Jan 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cue Biopharma, Inc. (CUE)
CIK: 0001645460
Period of Report: 2020-01-02

Reporting Person: Morich Frank (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-02	Stock Option (right to buy)	$16.31	A	8000	Acquired	2030-01-02	Common Stock (8000)	Direct

Footnotes

F1: Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy.